Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
American Journal of Cancer Research
|
September 21, 2016
EZH2 inhibitors transcriptionally upregulate cytotoxic autophagy and cytoprotective unfolded protein response in human colorectal cancer cells
Yao-Yu Hsieh, Hsiang-Ling Lo, Pei-Ming Yang
Pathology, Research and Practice
|
March 16, 2019
In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma
Yao-Yu Hsieh, Tsang-Pai Liu, Pei-Ming Yang
Journal of Personalized Medicine
|
September 19, 2020
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the <i>KRAS</i> (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature
Li-Wei Liu, Yao-Yu Hsieh, Pei-Ming Yang
Molecular Oncology
|
October 16, 2023
Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance
Yao-Yu Hsieh, Jia-Ling Du, Pei-Ming Yang
International Journal of Molecular Sciences
|
June 24, 2022
Long Non-Coding RNA <i>MIR31HG</i> Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells
Ching-Chung Ko, Yao-Yu Hsieh, Pei-Ming Yang
Toxicology and Applied Pharmacology
|
June 20, 2022
Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4)
Yao-Yu Hsieh, Ya-Wen Cheng, Po-Li Wei, et al.
Royal Society Open Science
|
December 20, 2018
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Tsang-Pai Liu, Yao-Yu Hsieh, Chia-Jung Chou, et al.
International Journal of Cancer
|
December 20, 2019
Comparing the effectiveness of different EGFR-TKIs in patients with EGFR mutant non-small-cell lung cancer: A retrospective cohort study in Taiwan
Yao-Yu Hsieh, Wei-Tse Fang, Yu-Wen Lo, et al.
Biomolecules
|
April 25, 2020
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner
Pei-Ming Yang, Yao-Yu Hsieh, Jia-Ling Du, et al.
Cancer Science
|
February 11, 2012
Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy
Yao-Yu Hsieh, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
American Journal of Cancer Research
|
September 21, 2016
EZH2 inhibitors transcriptionally upregulate cytotoxic autophagy and cytoprotective unfolded protein response in human colorectal cancer cells
Yao-Yu Hsieh, Hsiang-Ling Lo, Pei-Ming Yang
Pathology, Research and Practice
|
March 16, 2019
In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma
Yao-Yu Hsieh, Tsang-Pai Liu, Pei-Ming Yang
Journal of Personalized Medicine
|
September 19, 2020
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the <i>KRAS</i> (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature
Li-Wei Liu, Yao-Yu Hsieh, Pei-Ming Yang
Molecular Oncology
|
October 16, 2023
Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance
Yao-Yu Hsieh, Jia-Ling Du, Pei-Ming Yang
International Journal of Molecular Sciences
|
June 24, 2022
Long Non-Coding RNA <i>MIR31HG</i> Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells
Ching-Chung Ko, Yao-Yu Hsieh, Pei-Ming Yang
Toxicology and Applied Pharmacology
|
June 20, 2022
Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4)
Yao-Yu Hsieh, Ya-Wen Cheng, Po-Li Wei, et al.
Royal Society Open Science
|
December 20, 2018
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Tsang-Pai Liu, Yao-Yu Hsieh, Chia-Jung Chou, et al.
International Journal of Cancer
|
December 20, 2019
Comparing the effectiveness of different EGFR-TKIs in patients with EGFR mutant non-small-cell lung cancer: A retrospective cohort study in Taiwan
Yao-Yu Hsieh, Wei-Tse Fang, Yu-Wen Lo, et al.
Biomolecules
|
April 25, 2020
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner
Pei-Ming Yang, Yao-Yu Hsieh, Jia-Ling Du, et al.
Cancer Science
|
February 11, 2012
Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy
Yao-Yu Hsieh, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
Page
of 5